Nový pohľad na liečbu generalizovanej myasténie gravis // SOLEN

Neurológia pre prax 1/2025

A new perspective on the generalized myasthenia gravis (gMG) treatment

Generalized myasthenia gravis (gMG) is a severe disease leading to risk of immediate life threatening and/or quality of life reduction in case of missing treatment. Even with an excellent therapeutic effect of conventional treatment, the treatment itself can lead to patient's quality of life worsening through unpleasant and/or serious adverse effects (AEs). Currently, in the latest recommendations for the gMG treatment, there is a very striking effort to identify patients with highly active gMG in whom early treatment escalation is needed in order to induce rapid gMG symptoms control and quality of life improvement, preferably with as little frequency and intensity of AEs as possible.

Keywords: generalized highly active myasthenia gravis, refractory MG, control of MG symptoms